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1 Molecular pathology of breast cancer
SR Lakhani
The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research & The Royal Marsden Hospital,
London, UK
Abstracts from Symposium Mammographicum 2002
University of York, 17–19 July 2002
The multistep model of carcinogenesis in the breast suggests a
transition from normal epithelium to invasive carcinoma via
non-atypical and atypical hyperplasia and in situ carcinoma.
The introduction of mammographic screening has led to the
increased detection of preinvasive disease, and this has high-
lighted deficiencies in the biology and classification of such
lesions. The excitement surrounding the development of DNA
microarray analysis and proteomics has raised expectations
about the role of these techniques in understanding the biology
and translating these data to clinical practice. Only a few years
ago, scientists studied disease initiation and progression in a
linear fashion, identifying and examining one cancer-related
molecule at a time. The recent development of technologies
that allow a large number of genes and gene products to be
analysed simultaneously has brought renewed interest to
breast cancer research, with the hope of identifying a unique
‘fingerprint’ for each tumour and hence individualised treat-
ment. To date, histopathological assessment has been at the
heart of clinical management – does the new technology herald
the end?
2 Hormone replacement therapy (HRT): indications and side effects
MI Whitehead
Department of Obstetrics & Gynaecology, King’s College Hospital, London, UK
Late submission, see page S22
The Collaborative Group on Hormonal Factors in Breast Cancer
has brought together and reanalysed about 90% of the world-
wide epidemiological evidence on the relation between risk of
breast cancer and use of hormone replacement therapy (HRT).
Data on 52,705 women with breast cancer and 108,411
women without breast cancer from 51 studies in 21 countries
were collected, checked and analysed centrally. Among current
users of HRT or those who ceased use 1–4 years previously,
the relative risk of having breast cancer diagnosed increased by
a factor of 1.023 (95% confidence interval [CI] 1.011–1.036;
2P = 0.002) for each year of use; the relative risk was 1.35
(95% CI 1.21–1.49; 2P = 0.00001) for women who had used
HRT for 5 years or longer (average duration of use in this group
11 years). Five or more years after cessation of HRT use, there
was no significant excess of breast cancer overall or in relation
to duration of use. There was no marked variation in the results
according to hormonal type or dose but little information was
available about long durations of use of any specific preparation.
Cancers diagnosed in women who had ever used HRT tended
to be less advanced clinically than those diagnosed in never-
users. In North America and Europe the cumulative incidence of
breast cancer between the ages of 50 and 70 in never-users of
HRT is about 45 per 1,000 women. The cumulative excess
numbers of breast cancers diagnosed between these ages per
1,000 women who began use of HRT at age 50 and used it for
5, 10 and 15 years respectively, are estimated to be 2 (95% CI
1–3), 6 (95% CI 3–9) and 12 (95% CI 5–20). Whether HRT
affects mortality from breast cancer is not known.
3 Breast cancer and hormone replacement therapy (HRT): collaborative reanalysis of data from 51
epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast
cancer
V Beral, for the Collaborative Group on Hormonal Factors in Breast Cancer
Secretariat, ICRF Cancer Epidemiology Unit, Radcliffe Infirmary, Oxford, UK
4 Hormone replacement therapy (HRT) and its effect on mammographic specificity and sensitivity
JC Litherland
Department of Radiology, Glasgow Royal Infirmary, Glasgow, UK
It is now widely recognised that the use of hormone replace-
ment therapy (HRT) can influence mammographic pattern.
Approximately 17–24% of women using HRT may have
demonstrable changes on sequential mammography consisting
either of a generalised increase in background density or focal
changes such as cyst formation or an increase in the size of
fibroadenomata. In addition to demonstrable change, HRT may
also lead to maintenance of breast density, so that the naturalBreast Cancer Research    Vol 4 Suppl 1 Symposium Mammographicum 2002
S2
involution usually seen with age is not visualised. As the
number of women taking HRT increases, and these women are
in the age group targeted by breast screening programmes,
there has been an increasing interest in the influence of HRT
on the sensitivity and specificity of mammography.
Over the past few years several studies have been published
addressing this issue and the results of these will be reviewed
within the lecture. Overall, there is evidence of a reduction in
sensitivity with HRT use, although this may be confined to
women with a dense background pattern only. In addition, there
is also evidence of decreased specificity in women taking HRT.
5 Technology update
KC Young
National Co-ordinating Centre for the Physics of Mammography, Royal Surrey County Hospital, Guildford, UK
Full field digital mammography has continued to develop.
There is now a remarkable variety of different designs. One
of the oldest (photo-stimulable phosphors) has received a
new lease of life with the introduction of dual reading tech-
nology at a 50 µm resolution. Systems using a selenium
detector plate with a 70 µm resolution are being introduced
this year. Such systems have the advantage of converting X-
ray energy directly to an electrical signal. A low dose system,
which uses a scanning technique with a linear array of silicon
detectors, has also been developed. Dual displays with
2000 × 2500 resolution are becoming standard. While such
systems may be readily introduced into a symptomatic role,
their use in screening remains problematic. All the digital
systems can overcome the latitude limitations of the tradi-
tional film screen mammography, and appear to offer advan-
tages in terms of image quality, particularly with better
contrast resolution. The overall contrast can also be opti-
mised for each image. The main limitations to the wider use
of this technology remain the high start-up costs and the lack
of proven clinical advantages.
7 Review of clinical trials
RE Hendrick
Department of Radiology & Lynn Sage Breast Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois,
USA
6 Computer aided detection
P Taylor
Centre for Health Informatics and Multiprofessional Education, Royal Free & University College London Medical School, London,
UK
Computer analysis of digitised mammograms is now remarkably
sensitive for the detection of calcifications and masses. This sen-
sitivity, however, is only achieved at low levels of specificity.
System developers have tried to get around this difficulty by
developing prompting systems, in which the computer algorithms
are used to alert film readers to possible areas of abnormality.
The idea is that the computer may be able to improve a radiolo-
gist’s, or radiographer’s, sensitivity while relying on his or her pro-
fessional judgement to maintain acceptable levels of specificity.
Research in the United States has shown that the algorithms
are sensitive and that prompting systems do not adversely
affect specificity. The evidence that they can improve radiol-
ogists’ sensitivity is less certain, although there are now
studies showing that improvements have been achieved. The
key unanswered question is what is the potential impact of
these tools on the decision-making of radiologists and radi-
ographers working in the UK screening programme? A large
scale evaluation, involving 50 film-readers, is underway to
assess this impact. Interim results will be presented at Sym-
posium Mammographicum. Issues include the significance of
abnormalities other than masses and calcifications, and the
relative importance of errors of detection and errors of
decision-making.
Clinical trials of full-field digital mammography to date have
compared sensitivity, specificity, and receiver operating charac-
teristic (ROC) curves of digital to screen-film mammography,
typically in paired studies of the two modalities. The largest
study to date has been conducted in women at two institutions
in the USA involving 6,736 paired examinations of women aged
40 and over presenting for screening mammography at the Uni-
versity of Colorado and University of Massachusetts Medical
Centers. Of 1,467 subjects recommended for additional evalu-
ation on at least one modality, 181 biopsies were performed,
yielding detection of 42 cancers. Nine cancers were detected
only by digital mammography, 15 only by screen-film mammo-
graphy, 18 by both, and 8 by neither modality. The difference in
cancer detection was not statistically significant (P > 0.1).
Digital mammography resulted in fewer recalls than screen-film
(799 versus 1,007; P < 0.001). ROC curve areas were 0.74
for digital and 0.80 for screen-film (P > 0.1). Results of other
trials conducted to date, primarily diagnostic studies for regula-
tory approval, will also be described, along with the design of
the National Cancer Institute sponsored American College of
Radiology Imaging Network (ACRIN) DMIST study of 49,500
women, which is currently underway.Available online http://breast-cancer-research.com/supplements/4/S1
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8 Reconstruction
RM Rainsbury
Oncoplastic Breast Unit, Royal Hampshire County Hospital, Winchester, UK
The widespread popularity of breast-conserving surgery
coupled with frequency of cosmetic failure has led to the devel-
opment of new oncoplastic techniques, which can avoid a poor
cosmetic outcome. These techniques provide a ‘third option’ to
wide excision or mastectomy in three different ways. Firstly,
they extend a very wide excision of breast tissue without risk of
major deformity. Secondly, they extend the scope of conserva-
tion to patients with larger tumours, avoiding mastectomy
without compromising adequate resection. Thirdly, they can be
used to avoid mastectomy in patients with local recurrence and
correct unacceptable deformities following previous breast-
conserving surgery.
When mastectomy is unavoidable, a skin-sparing approach
minimises scarring and optimises the cosmetic result without
compromising oncological principles or disease control. The
breast can be resected and reconstructed through a small
central aperture, using the native skin envelope to mimic a
breast of life-like shape, size and ptosis. In future, new
approaches to preoperative assessment are likely to identify
patients who will benefit most from these new oncoplastic pro-
cedures. The UK has launched a unique programme for training
in all aspects of diagnosis, resection, reconstruction and clini-
cal management. This exciting new development heralds the
birth of the oncoplastic breast surgeon.
9 Imaging implants
AJ Potterton
Department of Radiology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Implants are used for breast augmentation and for reconstruction
following surgery. Magnetic resonance imaging (MRI) is the
modality of choice for evaluating such breasts with a higher sensi-
tivity and specificity than mammography or ultrasound for detect-
ing implant rupture and an ability to assess adjacent tissues.
Evaluation is tailored to the clinical setting. Sequences are
chosen to differentiate fat, fluid and silicone. Where there is
suspicion of malignancy, dynamic contrast enhanced
sequences are included.
Indications for imaging include suspected rupture, fluid collec-
tions, implant migration or a palpable mass. Implant rupture may
be intracapsular or extracapsular. MRI is the most reliable modal-
ity for identifying and characterising rupture (sensitivity 95%,
specificity 93%). The ‘linguine’ sign due to the collapsed implant
shell has the highest sensitivity. Where there is extracapsular sili-
cone, MRI can document the extent of migration. Examples of
normal and abnormal implants will be demonstrated.
There is no evidence that implants result in an increased risk of
breast cancer nor of any adverse effect on stage at presenta-
tion. Similarly there is no evidence that breast reconstruction
delays diagnosis of local recurrence. Contrast enhanced MRI
may be the most accurate method for detecting recurrence but
there have been no studies to evaluate routine MRI surveillance.
10 When do women really want to attend screening?
MG Wallis and S Wright
Warwickshire, Solihull & Coventry Breast Screening Unit, Coventry & Warwickshire Hospital, Coventry, UK
By 2004 the National Health Service Breast Screening Pro-
gramme (NHSBSP) is expected to deliver 40% more work by
expanding to the age of 70 and two views. Additionally the NHS
Plan charges the NHS with delivering improved access to all ser-
vices but most particularly Primary Care. We aimed to investigate
women’s preferences regarding day and time of both screening
and contacting the screening office. A self completed postal
questionnaire was sent to a random 50% sample of women
attending for breast screening between April and June 2001.
Eight hundred and thirteen of the 1,396 questionnaires were
returned, giving a response rate of 58%. Of these returns
approximately half expressed a preference in day to be screened,
but Saturday was the least popular option. Of the under 64s,
54% would prefer to be screened before 10 a.m. and after
4 p.m., compared with only 12% of women over 64 years.
Seventy-eight per cent of women wanted to contact the screen-
ing office by phone and 49% between 8 a.m. and 12 noon.
Extending hours of access sounds politically attractive and
improves utilisation of expensive capital equipment. There is little
enthusiasm among women attending screening, particularly in
the over 64s. However, for a small but significant number of
younger women access outside their working hours is preferable.Breast Cancer Research    Vol 4 Suppl 1 Symposium Mammographicum 2002
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11 A customer satisfaction measuring instrument for women using the breast screening service:
preliminary development and testing
S Wright, MG Wallis and C Wright
Warwickshire, Solihull & Coventry Breast Screening Unit, Coventry & Warwickshire Hospital, Coventry, UK
Women who attend for breast screening are in general not
motivated by ill health. The benefit of any such programme
depends upon repeated use and satisfied clients are more
likely to continue the relationship with their health care
provider. However, evaluation of satisfaction with the service
is impeded by the lack of a specific tool for use within this
target population. The purpose of the present study was to
develop and conduct preliminary testing of the properties of
a customer satisfaction measuring instrument (CSMI) that
reflected aspects of importance to the users and providers
of the breast screening service, hence ensuring content
validity of the tool. Development and testing involved four
studies and resulted in a 23 item CSMI, which comprised six
dimensions addressing location, arrival at the unit, the mam-
mogram, the breast screening service, the staff and
information.
12 Mammography and women over 65
S Chandrasekharan, FA Macneill, SK Marsh and P Sauven
Colchester and Chelmsford Breast Unit, Essex County Hospital, Colchester, UK
Aim: Self-referral mammography is available for all women over
the age of 65. In our unit 80% of women in the 50–64 year age
group and 15% in the over 65 age group attend for screening.
The aim of the study was to assess why only a small percent-
age of women referred themselves for screening.
Method: This was mainly a postal questionnaire study (sympto-
matic patients were given the questionnaires by the clinician).
Results: One hundred and seventy-five questionnaires were sent
and 101 (57.7%) were returned. The main reason for self-referral
was reminder by radiographers (43%) and the credit card
reminder (26%) which is used in our unit. Of non-attendees,
68% thought it was not important to attend after the age of 65.
Discussion: In this small study we have shown that older women
are still not aware of their risks with regard to breast cancer.
Women believe that because screening stops at 64 their risk of
getting breast cancer also stops. This study shows that radiogra-
phers have a strong influence on women attending screening.
Conclusion: Women over 65 need more education about
breast cancer both with regard to their risks and why regular
screening is valuable. The extension of screening age may
address some of these issues.
13 A review of screen detected breast cancers among aboriginal women in Western Australia
EJ Wylie, J Tresham and J Councillor
BreastScreen Western Australia, Department of Health, Perth, WA, Australia
The cancer mortality of Australian indigenous people is higher
than non-indigenous people, but at the same time the
reported incidence of cancer is broadly similar for both
groups. The objective of the study was to determine whether
the screening cancer detection rate is similar for indigenous
and nonindigenous women.
Method: BreastScreen Western Australia (BSWA) is a free
mammographic screening service targeting women 50–69
years of age. BSWA records from January 1990 to Decem-
ber 2000 were reviewed. Women are routinely asked to indi-
cate whether they are of aboriginal or Torres Strait Islander
origin (ATSI).
Results: A total of 450,425 women were screened by BSWA
from January 1990 to December 2000. 2,314 cancers were
detected with a total cancer detection rate of 5.1 cancers per
1,000 women screened. 4,916 women of ATSI origin were
screened during this interval. 31 breast cancers were diag-
nosed, with a total cancer detection rate of 6.3 cancers per
1,000 women screened.
Discussion: Cultural, geographic and economic barriers exist
that limit indigenous women’s access to and the acceptability
of many western health initiatives, including screening mam-
mography. BSWA has a special obligation to make information
on and access to services as culturally acceptable as possible
to this group of clients.Available online http://breast-cancer-research.com/supplements/4/S1
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14 The accuracy of imprint cytology of breast core biopsy under ultrasound guidance
S Koshi, J Goligher, M Gottlieb, G Bradley, M Khan, R Reyes and TK Walters
The Clinical Breast Unit, Queen Mary’s Hospital, Sidcup, UK
Introduction: Histological analysis of core biopsy of breast
lesions takes a minimum of 24 h, but imprint cytology of a core
biopsy can be reported within an hour. This study validates the
accuracy of imprint cytology from core biopsy of breast lesions
obtained under ultrasound control.
Method: One hundred and fifty consecutive core biopsies from
breast lesions of 142 patients were performed. The cores were
placed on six microscopy slides to obtain imprint cytology.
Imprint cytology and routine histology of the cores were
assessed independently by two pathologists.
Results: See Table.
None of the imprints reported as malignant subsequently
proved to be benign and only one of the imprints reported as
benign subsequently proved to be malignant.
Conclusion: Imprint cytology of core biopsies correlates well
with subsequent histological results and could be used to
provide a rapid preliminary diagnosis. This rapidly available
technique could reduce anxiety in patients with benign lesions
and help treatment planning in patients with breast cancer.
15 UK National Health Service Breast Screening Programme (NHSBSP) multicentre image guided
biopsy trial: an update
The UK Mammotome Trial Group (W Teh, MJ Michell, ARM Wilson and P Britton) presented by B Shah
Edgware, King’s, Nottingham and Cambridge Breast Screening Units, Edgware, London, Nottingham and Cambridge, UK
This is an update on randomised control trials (RCTs) evaluat-
ing the efficacy of 11-gauge mammotome (Ma) to 14-gauge
core biopsy (CB). A total of 614 women with impalpable clus-
tered microcalcifications and/or distortions were prospectively
recruited in a multicentre (Edgware, King’s, Nottingham and
Cambridge) RCT. Specimen radiographs were obtained for all
biopsies performed for microcalcifications. Complete data for
585 women were analysed. Two hundred and ninety-three CB
and 292 Ma had been performed on 554 microcalcifications,
two distortions with microcalcifications and 29 distortions.
There are 191 cancers (32%) consisting of 54 invasive and
137 in situ carcinoma. Comparing CB and Ma, the absolute
sensitivity for ductal carcinoma in situ (DCIS) was 79.2% and
80%, respectively, with a complete sensitivity of 89.6% and
96.6%, respectively (P = 0.1). The absolute sensitivity for inva-
sive disease is 33.3% and 58.3%, respectively (P = 0.06).
Mammotomy is significantly less likely to under-stage malignant
disease when a B3 result is obtained compared to CB (17.5%
versus 64%, respectively). The analysis suggests that the
greatest benefit of mammotomy is in clustered microcalcifica-
tion with an indeterminate appearance and in minimising the
under-diagnosis of associated malignant disease.
16 Diagnosis of lymph node metastases by axillary node core biopsy in patients presenting with
primary operable breast cancer
A Damera, A Evans, E Cornford, ARM Wilson, HC Burrell, JJ James, D Macmillan, SE Pinder and IO Ellis
Helen Garrod Breast Screening Unit, City Hospital, Nottingham, UK
Preoperative diagnosis of axillary nodal metastases allows
selective axillary clearance in patients with confirmed nodal
metastases. This study examines the utility of ultrasound
guided core biopsy of abnormal axillary nodes in patients pre-
senting with operable breast cancer.
All patients presenting with suspected operable breast cancer
had their axilla scanned. Nodes were classified as abnormal if
the AP/width ratio was less than 2 or a focally thickened cortex
was seen. Abnormal nodes underwent ultrasound guided core
biopsy except a few where fine-needle aspiration (FNA) was
performed due to the proximity of axillary vessels.
In 50 women nodes were seen in 30, of which 17 were abnor-
mal. Thirteen cores and four FNAs were performed. Nine
(69%) of 13 cores were malignant and one of four FNAs were
malignant. Correlation with surgical histology will be performed.
Ultrasound can identify abnormal nodes in women with breast
cancer. Most of these nodes are malignant and this can be
confirmed with ultrasound guided core biopsy.
Imprints Cores
Inadequate 6 7
Benign 80 79
Atypical 5 2
Suspicious 2 0
Malignant 57 62Breast Cancer Research    Vol 4 Suppl 1 Symposium Mammographicum 2002
S6
17 Plastic surgery for patients with postmastectomy syndrome
NN Antonenkova, IV Zalutsky and AG Zhukovets
Department of General Oncology and Plastic Surgery, NN Alexandrov Research Institute of Oncology and Medical Radiology,
Minsk, Belarus
Objective: Improvement in the quality of life of patients given
definitive treatment for breast cancer.
Materials and method: The Institute has acquired a wide and
long-term experience in combination and multimodality treat-
ment of breast cancer patients. One of the complications of
such treatment is postmastectomy lymphoedema. This occurs,
according to different researchers, in 33.3–84.3% of the
cases. We have developed techniques of multimodal treatment
for postmastectomy lymphoedema including oral administration
of Cyclo-3 Fort, pneumatic compression, myostimulation by
magnetic induction and Iymph-drain surgical interventions
employing omentobrachyopexy. Forty-six patients received
such treatment.
Results: With microsurgical autotransplantation of the greater
omentum, oedema reduction made up 79.0 ± 2.28%, with its
transposition – 81.2 ± 3.18%. In two patients, the profile of
the missing breast was restored after correction of Iympho-
venous insufficiency; in one patient, excision of radiation ulcer
in the anterior thoracic wall was performed with plastic build-
ing of the defect.
Conclusion: The above method of multimodality treatment for
postmastectomy oedemas using plastic surgery is beneficial for
the rehabilitation of breast cancer patients, considerably
improving the quality of their life.
18 The mammographic appearances of benign mammary mucocele-like lesions
EJ Wylie and C Metcalf
Multidisciplinary Breast Clinic and Department of Diagnostic and Interventional lmaging, Royal Perth Hospital, Perth, WA,
Australia
Mucocele-like lesions of the breast were first described in the
pathology literature in 1986. No series of the mammographic
appearances of these lesions has been described. These
benign breast lesions are composed of minute multiple cysts
lined by uniform flat or cuboidal to columnar epithelium. Micro-
scopically, microcalcifications are frequently present within the
cysts and extravasated mucus. These lesions may mimic the
microcalcifications of ductal carcinoma in situ at screening
mammography.
Method: A review of the multidisciplinary breast clinic database
revealed 20 cases of mammary mucocele-like lesion diagnosed
at Royal Perth from January 1996 to December 2001.
Results: All lesions presented as impalpable mammographic
screen detected lesions. Nineteen lesions presented as clusters
of irregular calcification mimicking ductal carcinoma; one lesion
presented as a complex cystic mass at mammography and ultra-
sound. Fine needle aspiration yielded mucinous material. Core
biopsy confirmed mucocele-like lesion in 15 lesions. Seventeen
women underwent open biopsy following hook-wire localisation.
Discussion: Mammary mucocele-like lesions are rare screen
detected lesions that may calcify and mimic ductal carcinoma
in situ or present as complex cystic masses. Fine needle aspi-
ration of mucinous carcinoma and mucocele-like lesions may
yield mucin with scant epithelium. Core biopsy or excisional
biopsy is recommended to differentiate between these lesions.
19 Sloane Project: a prospective audit of screen detected ductal carcinoma in situ
A Evans, H Bishop, K Chambers, H Dobson, IO Ellis, A Hanby, O Kearins, G Lawrence, SR Lakhani, JC Macartney, 
AJ Maxwell, SE Pinder, ME Wheaton and MG Wallis
Sloane Project, West Midlands Cancer Intelligence Unit, University of Birmingham, Birmingham, UK
One thousand nine hundred and fifty-three non-invasive breast
cancers were diagnosed by the National Health Service Breast
Screening Programme (NHSBSP) in women aged 50–64
during the period 1999–2000. Prior to the introduction of
screening only 295 cases of ductal carcinoma in situ (DCIS)
were recorded in England and Wales in women in the same
age band. The reason for this is that the trademark characteris-
tic of microcalcification in the majority of DCIS cases is easily
visualised radiologically on a mammogram. Consequently, with
the introduction of breast screening, the incidence of this type
of cancer has been increasing rapidly, and DCIS now accounts
for approximately 20% of all cancers detected by the
NHSBSP.
The invasive potential of each DCIS is uncertain and accord-
ingly the optimal method of treatment in every case is unclear.
The Sloane Project aims to address this question. As a
prospective audit recording particular characteristics in terms of
radiological and pathological appearance and details of surgical
and adjuvant treatment, the audit will compile a database of
potentially 6,000 DCIS cancers over 3 years. These women will
be followed up and the incidence of local recurrence, meta-Available online http://breast-cancer-research.com/supplements/4/S1
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stases and deaths will be determined. This information will allow
us to calculate survival, to suggest what might be the optimal
treatment for DCIS, to identify prognostic indicators and to
examine the role of margins and adjuvant therapy on outcome.
20 Electrical impedance scanning: a new imaging technique for evaluating microcalcification in the
breast?
PJ Kneeshaw1, PJ Drew1 and A Hubbard2
1Academic Surgical Unit and 2The Hull and East Yorkshire Breast Care Unit, Castle Hill Hospital, Hull, UK
Objective: Electrical impedance scanning (EIS) is a new
imaging modality that utilises the different dielectric properties
of malignant and benign cells. The aim of the study was to eval-
uate the efficacy of EIS in the evaluation of clinically occult
microcalcification in the breast.
Method: Women with areas of clinically occult microcalcifica-
tion detected on X-ray mammography underwent EIS of the
breast. A targeted high-resolution mode was used to assess
the area of microcalcification. A bright white spot over the area
of microcalcification was interpreted as a positive result. The
EIS data were also analysed by post-processing, evaluating
peak and average capacitance and conductivity over the region
of interest compared to a normal control area in the same
breast.
Results: Thirty-five women were recruited (mean age 57, range
42–74 years). Histological diagnosis (n = 29) revealed: inva-
sive disease (n = 1), invasive + ductal carcinoma in situ (DCIS;
n = 4), DCIS (n = 4) and benign (n = 20). The remaining
patients (n = 6) had radiologically benign microcalcification
requiring no formal histological assessment. For the detection
of malignancy using EIS imaging alone the sensitivity, speci-
ficity, positive and negative predictive values were 44.4%,
53.8%, 25.0% and 73.7%, respectively. Post-processing
analysis improved the overall accuracy, with corresponding
values of 55.6%, 88.5%, 62.5% and 85.2%. The difference in
mean conductivity between malignant and benign lesions in the
white spot region of interest was significant (P = 0.034).
Conclusion: EIS is able to differentiate malignant from benign
disease associated with clinically occult microcalcification.
21 Assessment of full field digital mammography (FFDM) detected microcalcification is not
hindered by low spatial resolution
L Bartella, N Perry, KC Young, CP Lawinski and D Evans
NHS Breast Screening Programme and The Princess Grace Hospital, London, UK
Background: Full field digital mammography (FFDM) seems
set to replace conventional film-screen technique. Concern has
been raised over FFDM diminished spatial resolution
(5–6 Ip/mm). If valid, this could compromise detection of calci-
fication and diagnosis of ductal carcinoma in situ (DCIS).
However, in our centre we were not able to perceive any differ-
ence between microfocus magnification and on-screen magnifi-
cation when assessing microcalcification.
Aim: To evaluate replacement of analogue microfocus tech-
nique by on-screen digital magnification for microcalcification,
and to analyse the relative importance of spatial resolution
versus contrast detail test scores.
Methods: We performed phantom image quality testing on our
digital unit (GE 2000D), using the TORMAX and TORMAM
phantoms. We subsequently compared these results with
average scores for over 90 film-screen mammography systems.
Results: Although our digital unit had a lower spatial resolution
(6–7 Ip/mm) than the film-screen systems (up to 15 Ip/mm),
both TORMAX and TORMAM scores were superior for digital
soft-copy reporting compared to hard-copy reporting, film-
screen technique and analogue microfocus magnification.
Conclusion: Despite lower spatial resolution, the superior con-
trast and image manipulation abilities of FFDM obviate the
need for conventional microfocus magnification in the radio-
graphic work up of microcalcifications. Sufficient information is
provided on FFDM upon which to base a decision to proceed
to diagnostic interventional procedures such as core biopsy or
mammotome excision.
22 Computed radiography systems for mammography: an evaluation of image quality and dose
CP Lawinski1, DA Goodman2 and MA Whall3
1KCARE (King’s Centre for the Assessment of Radiological Equipment), King’s College Hospital, London, UK; 2East Anglian
Radiation Protection Service, Addenbrooke’s Hospital, Cambridge, UK; and 3Regional Radiation Protection and Physics Service,
Birmingham, UK
Computed radiography (CR) in mammography was initially
based on systems for general radiography. Dedicated mam-
mography CR systems are now available with improved
imaging capability, particularly in terms of spatial resolution.
The phosphor is carried on a clear backing plate and the reader
scans both sides of the phosphor simultaneously.Breast Cancer Research    Vol 4 Suppl 1 Symposium Mammographicum 2002
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Image quality data for both types of mammography CR system
was obtained using standard test objects. All acquired images
were printed onto film using a high-resolution laser printer and
were scored under standard viewing conditions. Certain
images were also scored as soft copy using a reporting work-
station. Breast dose was also assessed. The results were com-
pared to film screen data and to the National Health Service
Breast Cancer Screening Programme (NHSBSP) guidelines
on the introduction of CR systems for mammography.
In terms of low contrast sensitivity and small detail
detectability the performance of both designs of CR system
is similar to that of a modern film screen combination. The
measured values of high contrast resolution are close to the
nominal values derived from the pixel size but are signifi-
cantly poorer than for film screen imaging. Dose levels are
similar to that for a modern film screen combination. Both
CR systems meet the suggested NHSBSP standards for
image quality and dose.
23 Predicting breast cancer response to chemotherapy using quantitative magnetic resonance (MR)
imaging
LW Turnbull1, DJ Manton1, M Lowry1, A Maraveyas1, A Chaturvedi2, J Greenman1, L Cawkwell1, A Hubbard3, A Modi4 and M
Lind1
1Centre for MR Investigations, University of Hull, Hull, UK; 2Oncology Department, Princess Royal Hospital, Hull, UK; 3Breast
Screening Unit, Castle Hill Hospital, Hull, UK; and 4Academic Surgical Unit, Castle Hill Hospital, Hull, UK
Change in tumour volume may be a relatively late manifestation
of chemotherapy response in patients with inoperable breast
cancer. Recent studies suggest that quantifying water appar-
ent diffusion coefficient (ADC), microvessel permeability (Ktrans)
or water to fat signal ratio (WFR), using magnetic resonance
(MR) imaging or spectroscopy, may provide an early indication
of ultimate treatment response.
Imaging and spectroscopy were carried out prior to chemother-
apy (TP0) and shortly after the second (TP2) and final courses.
ADC was measured using echo planar imaging (EPI) (maximum
diffusion gradient weighting 680 s/mm2); Ktrans was measured
using dynamic T1-weighted gradient echo imaging (13 s tem-
poral resolution); WFR was measured using stimulated echo
acquisition mode (STEAM) spectroscopy (TE 135 ms); tumour
volume was measured using high resolution, three dimensional,
post contrast, fat-suppressed images (manually traced regions
of interest).
Preliminary results from five (of 35 recruited) women who
have completed their chemotherapy course (standard
regimen involving 5-fluorouracil, epirubicin and cyclophos-
phamide) demonstrated that all tumours responded. Both the
TP2:TP0 MRI volume ratio and the corresponding Ktrans ratio
accurately predicted response in all five cases. The corre-
sponding ADC and WFR ratios predicted response in three
out of five and four out of five cases, suggesting that they
may be less reliable indicators of final treatment efficacy.
Results from 25 out of 35 women (course completed) will be
presented.
24 Our experience in using magnetic resonance imaging (MRI) as an adjunct to mammography and
ultrasound in assessing response to neoadjuvant chemotherapy
B Dall, G Parkin, D Dodwell, S Lane, D Wilson and S Jervis
MRI Department, Cookridge Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Objectives: (1) Did early magnetic resonance imaging (MRI)
correctly identify ‘responders’? (2) Did MRI at the end of treat-
ment correctly identify residual disease?
Method: Patients were assessed with mammography, ultra-
sound and MRI prior to treatment and had a second MRI scan
after two pulses of chemotherapy. Mammography, ultrasound
and MRI were then repeated at the end of treatment. Response
at MRI was determined by a combination of size, morphological
appearance and enhancement profile.
Results: Eleven patients were studied. Four patients presented
with primary breast tumour and clinically enlarged axillary lymph
nodes. Seven patients presented with large tumours
(>30 mm). Patients were divided into responders/non-respon-
ders based on a greater than 50% reduction in size at mam-
mography and ultrasound at completion of treatment. In the first
group, there were three responders and one non-responder. In
the second group, there were four responders and three non-
responders. All responders were identified at the early MRI
scan. All patients had residual disease at surgery. MRI was a
useful adjunct to mammography and ultrasound but still tended
to underestimate the extent of residual disease.
Conclusion: (1) MRI provides additional information about
the extent of disease before and after chemotherapy treat-
ment. (2) Early MRI (after two pulses) predicted response to
chemotherapy.Available online http://breast-cancer-research.com/supplements/4/S1
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25 Evaluation of three different resolution workstations for reporting computerised radiography
mammographic images
ERE Denton, G Hurst, G Wivell and J Pilling
Breast Imaging Department, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
Using Fuji computerised radiography and a General Electric
PACS our unit now reports soft copy mammography images.
These are available for reporting on three monitors, a Path-
speed Diagnostic 2A workstation with two monitors each with
1728 × 2304 pixel resolution, a Pathspeed Diagnostic 2B with
two monitors each with 1200 × 1600 pixel resolution and an
image review workstation (IRW), which constitutes a Dell PC
with a 17” flat panel LCD screen with 1024 × 768 pixel resolu-
tion. Mammography reporting has traditionally been felt to
require the best possible resolution. This study has been
designed to show whether or not this is necessary.
We have evaluated standard mammography phantom images
(TORMAS and TORMAM) and a set of 50 mammograms with
known calcification to determine the resolution required for
reporting CR mammography. This has implications for other
units interested in computerised radiography as the costs of the
three reporting workstations range from £1,000 to £41,000.
26 Ductal carcinoma in situ (DCIS)
R Holland
National Expert and Training Centre for Breast Cancer Screening, University Medical Centre, Nijmegen, The Netherlands
Does the detection and proper treatment of ductal carcinoma
in situ (DCIS) contribute to mortality reduction? In other
words, does the detection of DCIS prevent the development
of metastatic invasive cancer and thereby death? Although
we assume that DCIS is the obligate pre-stage of most inva-
sive breast carcinomas, it is unlikely that all DCISs have the
potential to progress to an invasive process within the lifetime
of the patient. This assumption is based on histologic review
studies indicating that certain types of DCIS (the well differ-
entiated types) have a limited risk of progressing to an inva-
sive cancer. Recently, Böcker reported close genetic
similarity of well, intermediately and poorly differentiated
DCISs and distinct morphologic types of invasive breast
cancers. Further, Lampejo et al. reported a significant differ-
ence in disease-free survival and overall survival for patients
with invasive tumours with different types of DCIS compo-
nents. Patients with poorly differentiated DCIS components
had a poor prognosis and those with well differentiated DCIS
components had a very good one. We may conclude that all
fully developed DCISs have the potential to progress to an
invasive cancer. The time needed for this process, however,
is different for the poorly and well differentiated subtypes. For
the majority of the poorly differentiated DCISs this may take
less than 5 years, while for the well differentiated type it prob-
ably takes more than 10–15 years. Poorly differentiated DCIS
is the precursor of high-grade, and well differentiated DCIS of
low-grade invasive cancer. Therefore, the detection of the
poorly and intermediately differentiated DCIS is more impor-
tant in terms of effect on mortality than the detection of the
well differentiated subtype.
27 Invasive cancer
IO Ellis
Department of Histopathology, Nottingham City Hospital NHS Trust, Nottingham, UK
Breast screening detects a wide spectrum of breast cancer,
ranging from microfocal low-grade ductal carcinoma in situ
(DCIS) to large high-grade invasive cancer (Cowan et al.,
1991; Klemi et al., 1992; Rajakariar et al., 1995). It has been
proposed that detecting in situ cancer, particularly high-
grade DCIS, would prevent the development of high-grade
invasive cancer (Lampejo et al., 1994; Evans et al., 1997,
2001). It is well recognised that many low-grade, special inva-
sive cancers are identified at screening (Cowan et al., 1991;
Klemi et al., 1992; Porter et al., 1999). Such tumours have an
excellent prognosis but may be so indolent that they would
never have presented clinically or have threatened the life of
the patients. It has been proposed alternatively that a propor-
tion of these low-grade invasive tumours might de-differenti-
ate over time into more aggressive, less well differentiated
tumours (Tabár et al., 1999), although this was not found in
another screening programme (Hakama et al., 1995). Identifi-
cation and removal of such cancers when they are at a low-
grade would avoid such progression. Detection of high-grade
invasive cancers when they are small is clearly a means by
which screening could reduce breast cancer mortality. In
support of this possibility, it was shown in the two-county trial
in Sweden that histological grade 3 invasive cancers
detected when less than 10 mm have an excellent prognosis
(Tabár et al., 1999), while it is widely recognised that large
high-grade invasive cancers have a poor prognosis. In addi-
tion the presence of vascular invasion and lymph node metas-
tasis, which are associated with development of metastatic
disease, are rare in grade 3 tumours <10 mm, grade 2
tumours <10 mm and grade 1 tumours <20 mm, indicating
that detecting tumours under a certain size should be benefi-
cial (Evans et al., 2001).Breast Cancer Research    Vol 4 Suppl 1 Symposium Mammographicum 2002
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28 The epidemiologist’s perspective
SW Duffy
Department of Mathematics, Statistics and Epidemiology, Imperial Cancer Research Fund, London, UK
By examining the stage-shifts in mammographic screening
trials, and the fatality rates by stage, one can derive estimates
of which cancers detected at screening save most lives. We
partition the mortality avoided by screening into deaths pre-
vented by stage-shifting from invasive carcinoma of stage II or
worse to invasive carcinoma of stage I, and those prevented by
shifting from invasive carcinoma of stage I to ductal carcinoma
in situ. Using data from the Swedish Two-County Study, we
find that around 5% of the deaths avoided in the invited arm
were prevented by detection of ductal carcinoma in situ and
around 65% by stage-shifting from stage II+ to stage I within
the invasive carcinomas. Further results by tumour type and
grade are presented to quantify the size and timing of the future
mortality reduction from the cancers diagnosed.
29 Vacuum biopsy in the UK
MJ Michell
Department of Radiology, King’s College Hospital, London, UK
The first vacuum-assisted core biopsy (VACB) apparatus in the
UK was installed for clinical use with stereotactic guidance at
King’s College Hospital in 1998. Since then it has been incor-
porated into routine clinical practice for the assessment of non-
palpable mammographic abnormalities, particularly micro-
calcification and areas of architectural distortion not visible on
ultrasound examination, and more than 150 VACB procedures
are carried out per year. There are now more than 50 VACB
units in use in the UK.
The potential advantages of VACB over standard 14G core
biopsy are:
1. Larger samples obtained
2. No repeat insertion of the needle necessary
3. Haematoma evacuated during the procedure
4. More tissue available for histological examination
5. Sampling effective when probe positioned several millime-
tres away from the lesion
6. Improved calcium retrieval rates, particularly from small
clusters of indeterminate microcalcification
7. Fewer equivocal (B3, B4) results
8. Improved sensitivity for detection of invasive carcinoma in
an area of ductal carcinoma in situ
9. Marker clip deployment when mammographic marker is
removed.
The results of published studies together with data from the UK
trial of 14G core biopsy versus 11G mammotome will be dis-
cussed, and a strategy for future development of the use of
VACB in diagnostic and assessment centres in the UK will be
suggested.
30 Therapeutic applications of vacuum biopsy
ARM Wilson
Nottingham Breast Screening Training Centre, Nottingham City Hospital, Nottingham, UK
Core biopsy is now established as the first-line method for
breast biopsy and sensitivity for carcinoma of 90–95% can be
achieved. The quest for 100% accuracy of percutaneous biopsy
has led to the development of very large core biopsy methods;
vacuum assisted mammotomy (VAM) is the most successful
and widely used of these methods. VAM is available in 14, 11
and 8 gauge sizes (36, 100 and 300 mg per core). The 8-g
probe has been developed specifically for attempted complete
removal of small breast lesions. VAM is not suitable for excision
of malignant lesions but has a role in the removal for diagnosis
of borderline lesions and removal of confirmed benign lesions at
the patient’s request. Borderline lesions suitable for VAM
removal are papillary lesions, mucocele-like lesions and radial
scars. Nipple discharge associated with intraduct papilloma can
also be treated by this method. VAM can also be used to excise
fibroadenomas up to 30 mm in diameter. VAM is well tolerated
and has very few complications. For therapeutic excision VAM is
significantly cheaper than surgical biopsy.
31 Multicentre evaluation of stereotactic vacuum biopsies of mammographically indeterminate or
suspicious lesions
R Schulz-Wendtland1, U Kettritz2, I Schreer3, M Murauer4, K Rotter5 and SH Heywang-Köbrunner5
1Institute of Diagnostic Radiology, University of Erlangen-Nürnberg; 2Breast Centre Berlin-Buch; 3Breast Centre, University of
Kiel; 4Breast Centre, Deggendorf; and 5Institute of Diagnostic Radiology, University of Halle, Germany
Purpose: Vacuum biopsy (VB) promises excellent accuracy for
indeterminate lesions, including microcalcifications. The
purpose of this study is to check reproducibility and reliability in
high quality breast centres.Available online http://breast-cancer-research.com/supplements/4/S1
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Materials and method: From January 1996 to December
2000, more than 1,700 stereotactically guided vacuum biop-
sies (SVBs) were performed in five breast centres using a
defined standard. The data shown here are based on an
ongoing evaluation (presently 89% completed). Indications
were ACR III 16%, ACR IVa (moderate suspicion) 63%, ACR
IVb (suspicion) 63% and ACR V 5% of the cases.
Results: An additional 1.5% examinations were scheduled but
not performed (lesion too close to chest wall, microcalcifica-
tions not resolved). Among performed studies the examination
was terminated due to technical problems in 0.9% (90% due
to one biopsy table), bleeding (0.4%), or pain (0.1%). Nine per
cent of cases proved to be invasive carcinomas, 13% ductal
carinoma  in situ (DCIS) and 4% atypical ductal hyperplasia
(ADH). In four benign lesions the pathologist recommended
excisional biopsy, which confirmed the diagnoses. In the 73%
benign lesions diagnostic surgery could be avoided.
Conclusion: Standardised stereotactic VB is very accurate,
safe and cost effective.
References
1. Heywang-Köbrunner SH, et al.:  Minimally invasive stereotaxic
vacuum core breast biopsy. Eur Radiol 1998, 8:377-385.
2. Parker SH, et al.: Performing a breast biopsy with a directional,
vacuum-assisted biopsy instrument. Radiographics 1997, 17:1233-
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3. Schulz-Wendtland R, et al. Interventionelle methoden in der mam-
madiagnostik. Gynäkol Prax 2002, 26:63-78.
32 The effect of screening across the age spectrum
SW Duffy
Department of Mathematics, Statistics and Epidemiology, Imperial Cancer Research Fund, London, UK
Historically, the most hotly disputed issue in mammographic
screening is whether to screen the age group 40–49. The most
recently published combined analysis of the randomised trials of
breast cancer screening at a range of ages between 40 and 74
gives a 24% reduction in breast cancer mortality in association
with invitation to screening. The most recent combined analysis
of the trial results for women aged 40–49 at randomisation
shows a significant 18% reduction in association with invitation
to screening. The effect in those who actually receive screening
may be considerably greater. Evaluation of service screening pro-
grammes similarly suggests a mortality benefit in women aged
40–49. To achieve this benefit a greater commitment of financial
and human resources is required. The decision to offer organised
screening before age 50 will always vary, depending on the inci-
dence in this age group, societal attitudes and competing calls
on resources. However, breast cancer control in this age group
is a major issue, because the proportion of deaths due to breast
cancer is higher among younger women than among older
women. The age at which to stop screening is a less researched
question and a more difficult one. It is clear that there is a benefit
of screening women up to age 70, but how long that benefit lasts
if screening ceases at age 70, and what sort of non-intensive
regimen might be offered to older women is not clear. Some ten-
tative answers to these questions are proposed.
33 Progress report on integrating skill mix: the radiologist’s perspective
ERE Denton
Breast Imaging Department, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
The 4-tier model for new ways of working in breast radiography
has now been in place for 2 years. The role of the assistant
practitioner is established and eight practitioners are in post.
Advanced practitioners remain diverse, with differences in role
extension appropriate to the departments where they work. The
role of the lead practitioner has yet to be clearly defined.
I will explore the experiences of the four pilot sites, particularly
with regard to their differing needs for advanced practitioners. I
will discuss the training and continuing professional develop-
ment for radiographers undertaking this role extension.
34 Progress report on integrating skill mix: the radiographer’s perspective
B Young
Derby Breast Unit, Derby City General Hospital, Derby, UK
Radiographers are the core people required in developing the
proposed ‘4 Tier Structure’ of the National Health Service
Breast Screening Programme (NHSBSP) Skill Mix Project.
Radiographers are needed to train and supervise the level one
tier, assistant practitioners. These people will have, in the main,
little or no experience of breast units or even radiography, and
will need quite close and detailed supervision.
Radiographers will still, in most units, remain as the lynchpin
workers in the screening and symptomatic clinics, at least for
the next few years while the level one workers are being
trained. These radiographers will be essential for maintaining
the service at its present level and for the future extension and
expansion of the programme.Breast Cancer Research    Vol 4 Suppl 1 Symposium Mammographicum 2002
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Suitably enthusiastic radiographers will be required to train into
the advanced level practices as identified by their particular units.
In time and with proper training it may be that the future lead
practitioners within this 4-tier structure will be radiographers.
35 Progress report on integrating skill mix: the college perspective
A Cattell
The College of Radiographers, London, UK
Pilot testing of the ‘4 Tier Structure’ for radiography in mam-
mography screening has been completed in four sites. A
number of positive outcomes have been identified and there
are proposals to introduce the model to other sites. A frame-
work for pay and conditions of service for radiographers at all
levels will be presented to underpin the new structure. The
scope of the pilots included development of all four tiers,
including lead/consultant practitioner.
Criteria for consultant therapists have been developed and
guidance for employment issued by the Department of Health.
The paper will discuss the opportunities for the consultant
radiographer role within the screening service and consider the
implications for future service delivery.
36 Extent and stage of breast cancer
FJ Gilbert
Department of Radiology, University of Aberdeen, Aberdeen, UK
The extent and stage of breast cancer at initial presentation
determines treatment options and prognosis. Pre-operative
disease extent is determined by mammography and image
guided biopsy, although magnetic resonance imaging (MRI)
may show further multifocal or multicentric disease. Histologi-
cal assessment will give tumour size, type, grade, hormone
receptor status and the presence of vascular invasion;
however, a variety of imaging techniques can contribute to this
information and perhaps give an in vivo functional assessment
of tumour physiology. Lymph node involvement has been
shown to have important prognostic status and is assessed by
surgery or sentinel node biopsy. Ultrasound, MRI and nuclear
medicine techniques, including positron emission tomography
(PET), give variable results in the assessment of the axilla. Clini-
cal assessment of tumour response in the neo-adjuvant setting
is unreliable and imaging can more accurately measure tumour
size and residual disease.
The contribution of mammography, ultrasound and MRI will be
discussed together with a review of the potential contribution
of the less commonly used nuclear medicine techniques and
PET. The functional imaging techniques are being explored and
may be used in the future to tailor patient management, particu-
larly in the use of chemotherapy.
37 Recording breast screening decisions: human factors and new technology
J Hatton, DS Wooding, KJ Purdy, SM Bateman, AG Gale and HC Cowley
Institute of Behavioural Sciences, University of Derby, Derby, UK
The Personal Performance in Mammographic Screening (PER-
FORMS) self-assessment scheme was designed to give
radiologists insight into their own breast screening diagnostic
performance skills. Originally conceived solely as a paper-
based approach, the scheme has been very successful and
consequently has expanded. Currently, a handheld computer
is utilised, both to record an individual’s opinions about each
case examined and to provide some initial immediate feedback
on the accuracy of their decisions. Unfortunately, the complex-
ity of the scheme has now far outstripped the recording tech-
nology used, which affects both current usability and limits
future enhancements. This paper describes the factors
involved in the redesign of a new state of the art system for
recording radiologists’ decisions in breast screening that
could have more widespread applicability outside the self-
assessment scheme.
Human factors methods have been implemented to analyse
users’ needs and determine the hardware requirements. A wide
range of potential systems have been considered, including
voice-operated, augmented reality and tablet computers. The
availability of a Windows-based Webpad provides the opportu-
nity of developing an easy to use system that can provide
expanded information to the radiologist. Ongoing studies are
investigating the design of the final user interface, and launch
of the new system is anticipated in 2003.Available online http://breast-cancer-research.com/supplements/4/S1
S13
38 Image features of true positive and false negative cancers in screening mammograms
S Meeson, KC Young, MG Wallis, J Cooke, A Cummin and ML Ramsdale
National Co-ordinating Centre for the Physics of Mammography, Royal Surrey County Hospital, Guildford, UK
The location, tissue background and imaging characteristics of
true positive and false negative screens of breast cancers have
been studied. These data can aid decisions in optimising the
display of mammographic information, with the objective of mini-
mizing false negative screens. Screening mammograms for four
groups of women were digitised: those with screen detected
cancers, those with false negative interval cancers, and
matched normals for both groups. The optical density (OD) dis-
tribution in the main breast region of each mammogram was
determined. The OD in three regions of interest around the
cancers were also measured: corresponding to the cancer
centre, its outline, and a ring of background tissue. Cancer loca-
tions were mapped and warped onto a typical image. Where a
cancer was detected by calcifications alone it had a relatively
low probability of being a false negative interval cancer. The
mean OD differences between the cancer and the cancer back-
ground region were approximately a factor of two lower in dense
breasts rather than in other breast types. Poorly defined masses
that became interval cancers had mean OD differences that
were approximately of 0.1 OD lower than those that were
detectable by screening. Of the false negative cancers 22%
were located near the chest wall edge of the mammograms,
compared to 10% of the true positives. The results indicate the
importance of effectively displaying information in the lighter
areas of the mammogram, corresponding to glandular tissues.
Where the cancer mean OD differences are low, as measured
for some poorly defined masses, there is an increased risk of a
false negative interval cancer. Particular attention should be
given to the chest wall area of the film, especially in the lower
retroglandular region, during routine screening.
39 Comparative effectiveness of magnetic resonance imaging in breast cancer (COMICE trial)
LW Turnbull, S Barker and GP Liney
Centre for Magnetic Resonance Investigations, University of Hull, Hull Royal Infirmary, Hull, UK
The overall aim of the comparative effectiveness of magnetic
resonance imaging in breast cancer (COMICE) trial is to deter-
mine the potential benefits of the addition of magnetic reso-
nance imaging (MRI) to the routine techniques employed for
Ioco-regional staging of primary breast cancer, to both the
patient and the National Health Service.
The study objectives are to evaluate the role of MRI in reducing
the re-operation rates following primary excision between those
planned by conventional triple assessment and those planned
by triple assessment plus DCE MRI. Additionally, an economic
evaluation from a societal perspective of the cost-effectiveness
between the two arms will be performed.
The study design consists of a multicentre, randomised, con-
trolled, open, fixed sample, parallel group trial with equal ran-
domisation, of women with biopsy proven primary breast
cancer who are scheduled for wide local excision. Patients
(1,850) will be randomised to receive MRI or no further investi-
gations. A pragmatic approach to trial design has been chosen
so that results will be generalisable in clinical practice and to
reduce unnecessary trial costs that are protocol driven.
Additional factors examined include the following: studying ipsi-
lateral breast tumour recurrence rates; subsequent chemother-
apy/radiotherapy rates; quality of life issues; risk factors for
referral for MRI; accuracy of loco-regional staging; percentage
of patients undergoing a change in clinical management after
MRI; and follow up of MRI only detected lesions.
40 Magnetic resonance imaging (MRI) in the assessment of patients with breast carcinoma: an
audit of accuracy
MA AI-Attar and PN Malcolm
Department of Radiology, United Lincolnshire Hospitals, Pilgrim Hospital, Boston, UK
The aim of this audit was to assess the accuracy of breast 
magnetic resonance imaging (MRI) in patients with biopsy
proven breast carcinoma. Indications were detecting multifocal
disease, assessing extent of primary tumour and excluding
recurrence.
Nineteen patients with known breast carcinoma detected on
mammography, ultrasound or clinical examination were referred
for MRI at 1T with bilateral breast coils. Pre-contrast and
dynamic post contrast scans with subtraction were performed.
Nineteen patients had 21 histologically proven lesions. These
included 13 invasive ductal carcinoma, two invasive lobular car-
cinoma, one medullary carcinoma and five benign lesions. MRI
detected all of these and eight new lesions. Histological confir-
mation was available on two of eight new lesions detected by
MRI. These represented 5- and 7-mm foci of invasive ductal
carcinoma, one correctly predicted to be malignant in the
contra-lateral breast. The other, thought to be benign, was
removed at wide local excision of the known carcinoma. Six of
the eight lesions had benign MRI features. Eleven months of
clinical follow up revealed no abnormality.Breast Cancer Research    Vol 4 Suppl 1 Symposium Mammographicum 2002
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Two follow up scans following surgery and radiotherapy were
normal. Nine months of clinical follow up revealed no recurrence.
We concluded that breast MRI is a reliable adjunct in pre-opera-
tive assessment and follow up of patients with known carcinoma.
41 Breast magnetic resonance imaging (MRI) – common pitfalls: a pictorial representation
B Dall, JC Liston, D Wilson and S Jervis
MRI Department, Cookridge Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK
1. Movement artefact: an apparent enhancing lesion on the
subtraction images must be confirmed on the pre-subtrac-
tion series.
2. Vessels: tortuous vessels can be misleading. Three-dimen-
sional reconstruction is useful in differentiating vessels from
focal nodules.
3. Lymph nodes: normal intramammary lymph nodes enhance
and do not always have a typical ‘C’ shape. Review of the
mammogram can be useful.
4. Lobular carcinomas: magnetic resonance imaging (MRI) is
particularly useful in diagnosing EXTENT of this difficult
tumour subgroup. The enhancement profile, however, is
often benign with slow and modest uptake. It is particularly
important to review the MRI in conjunction with the triple
assessment.
42 Roadworks ahead: a collaborative approach to process redesign
E Boal, P Durning, C Mcllveney, G Naisby and IA Cheema
Symptomatic Breast Service, James Cook University Hospital, Middlesbrough, UK
The symptomatic breast service at James Cook University Hos-
pital has recently undergone a pathway review, the catalyst for
the review being the Cancer Services Collaborative (CSC)
Phase II programme, which began in April 2001. A pathway
review had previously taken place in 1998, with one of the aims
being to provide a one-stop clinic allowing regular analysis of
variants to prove clinical effectiveness and service efficiency.
Due to service pressures, one of which was the impact of the
2-week wait, not all patients requiring the one-stop service
could receive triple assessment. This was in the main due to
lack of clinic time along with mammography and ultrasound
availability. Using the CSC methodology the current process
was mapped, redesigned and audited. The changes have
resulted in: extending the new patient clinic, with greater mam-
mography and ultrasound availability; where patients require
ultrasound and mammography outside the clinic appointments
can be booked within the clinic. The MDT has been moved
from prior to the breast clinic to post clinic, allowing more timely
discussion of patients both before and after surgery. Acquisi-
tion of a computer printer, projector and network facilities for
the MDT has resulted in the ability to enter data in real-time and
generate referrals to Oncology.
43 Quality management in the 21st century
S Munslow and MG Wallis
Breast Screening Unit, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK
Quality management systems in the 21st century should not be
unwieldy and over-documented tomes, but should be used to
reflect the organisation’s policy, objectives and commitment to
quality.
Quality management systems should be used as the basis for
continually improving business performance with a more flexi-
ble ‘process based’ management approach rather than the
earlier, somewhat regimented, ‘system based’ style.
Our aim, through the use of illustration, is to provide an informa-
tive view of the requirements of the 21st century quality man-
agement system [1] and the role and responsibilities of the
quality manager.
Reference
1. IS09001: 2000: Quality Management System Requirements.
44 It ain’t what you do, it’s the way that you do it – that’s what gets results
S Munslow and MG Wallis
Breast Screening Unit, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK
Getting the right result to the right woman has featured
heavily in the past 12 months. All breast screening services
have been called upon to ensure that they have adequate
safeguards in place to support the ‘right results’ process.
Coventry’s approach through its quality management system
was fortified by process mapping exercises. Maps are used
to illustrate how work gets done in an organisation. They rep-
resent a snapshot in time that shows the specific combination
of functions, steps, responsibilities and timelines. They can
also identify significant opportunities for improvement. Coven-Available online http://breast-cancer-research.com/supplements/4/S1
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try’s approach was benchmarked for use by the National Co-
ordination Committee for administration and clerical staff
within breast screening and has been successfully adapted
for the breast screening services in the West Midlands
region. This informative visualisation is used to illustrate the
process.
45 Is pre-operative ultrasound assessment useful in the diagnosis of radial scars (RS)/complex
sclerosing lesions (CSL)?
DC Windmill, RM Watkins, PA Jones and JR Steel
Primrose Breast Care Centre, Derriford Hospital, Plymouth, UK
Many screen-detected radial scars (RS)/complex sclerosing
lesions (CSL) are associated with malignant disease. The role of
ultrasound in pre-operative evaluation is uncertain. Our aim was
to determine whether ultrasound was able to detect associated
pathology in such lesions. The ultrasound scans of 38 women
(age range 37–65 years) with a definitive diagnosis of RS/CSL
at excision biopsy were reviewed by one radiologist who was
blinded to the identity of the patients and their previous ultra-
sound reports. Eight features were reviewed and, based on
these, a probability of malignancy was recorded on a scale of 1
to 10. The radiologist’s report and definitive histology were com-
pared. Lesions were not visible on ultrasound in eight patients
(21%). Three patients had invasive carcinoma; their scores were
8, 7 and 2 (mean 5.7). Of two patients with ductal carcinoma in
situ, scores were both 6. Combining the scores for those with
associated malignant pathology gave a mean score of 5.8. The
mean score of patients with benign RS/CSL was 4.7. Three
ultrasound features were found in all cases with associated
malignant disease; posterior shadowing, an hypo-echoic margin
and the absence of microlobulation. However, these were also
present in the majority with benign RS/CSL. Ultrasound tended
to underestimate the size of the lesion, independent of its nature.
Pre-operative ultrasound cannot reliably predict the presence
of pathology associated with RS/CSL, but a larger series is
required to confirm these findings.
46 Can ultrasound reliably localise radial scars (RS)/complex sclerosing lesions (CSL) prior to
excision biopsy?
DC Windmill, JR Steel, PA Jones and RM Watkins
Primrose Breast Care Centre, Derriford Hospital, Plymouth, UK
Traditionally, mammography has been used to localise radial
scars (RS)/complex sclerosing lesions (CSL) prior to excision
biopsy. Our aim was to evaluate the adequacy of pre-operative
ultrasound. Fifty-eight consecutive women (age range
36–72 years) who had a definitive diagnosis at excision biopsy
of RS/CSL were identified between January 1997 and January
2002. Twenty-eight patients underwent pre-operative ultra-
sound (US) localisation and 30 mammographic (MG) localisa-
tion (29 wire and one surface marker). The size of the lesion,
weight of specimen and adequacy of excision were recorded.
Successful localisation was achieved in all patients. In patients
with an entirely benign RS/CSL the median size of the lesion
was 14.5 mm (range 9–20 mm) in the US localisation group
and 11 mm (range 4–20 mm) in the MG localisation group.
Median weight of the specimens was 16 g (range 6–65 g) in
the US group and 15 g (range 7–45 g) in the MG group. Eight
(35%) of 23 biopsies were greater than 20 g in the US group
compared with five (19%) of 26 in the MG group. By Fisher’s
exact test there was no significant difference (P = 0.3320). In
patients with malignant disease associated with a RS/CSL, re-
excision was required in one of three in the US group and two
of four in the MG group.
Pre-operative US localisation compares favourably with MG
techniques for excision biopsy of RS/CSL.
47 An extended role for ultrasonographers in the evaluation of breast disease: initial experiences
PJ Kneeshaw1, R Tetlow2, PJ Drew1 and A Hubbard2
1Academic Surgical Unit and 2The Hull and East Yorkshire Breast Care Unit, Castle Hill Hospital, Hull, UK
Aims: With the continuing increase in workload of breast
assessment units, the role of specially trained ultrasonogra-
phers able to perform unsupervised invasive procedures
remains unclear.
Method: Between January and December 2001, patients from
the Hull and East Riding Breast Care Unit underwent invasive
procedures performed under ultrasound control by a specially
trained ultrasonographer.
Results: Seven hundred and twenty-eight procedures were
performed (age range 12–90, mean age 53 years), which
included 175 fine needle aspirations (FNAs) and 389 core
biopsies. The histology/cytology results were malignant in 230,
suspicious of malignancy in 8, benign but uncertain of malig-
nant potential in 29, benign in 231 and unsatisfactory/normal
tissue in 66. Of the FNAs, 20.9% were considered inadequate
(acceptable level <25%, National Health Service Breast
Screening Programme). Further ultrasound-guided proceduresBreast Cancer Research    Vol 4 Suppl 1 Symposium Mammographicum 2002
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included 20 successful wire localisations, 124 aspirations of
cysts and 13 abscess aspirations. In this series one patient suf-
fered a haematoma following a core biopsy.
Conclusion: We conclude that extending the role of ultrasono-
graphers is safe, consistent with current diagnostic require-
ments and is an appropriate use of resources for the future.
48 Comparison of image quality between mammograms performed by an assistant practitioner and
by screening radiographers
AE Tuson, D Seddon, CA Hopkins and AJ Maxwell
Bolton, Bury & Rochdale Breast Screening Programme, Royal Bolton Hospital, Bolton, UK
Bolton is one of the four national development sites for skill mix
in the UK National Health Service Breast Screening Pro-
gramme. Two assistant practitioners have been trained in-
house to perform mammography; one (AET) commenced
training in September 2000, and the other in April 2001. AET
has now been performing mammography under indirect super-
vision for several months.
Fifty mammographic examinations performed recently by AET
and 50 performed by radiographers with the Certificate of
Competence in Mammography were randomly selected. All
100 examinations were performed in the same screening unit
over the same period of time. Examinations on ‘difficult’ women
(e.g. in a wheelchair) were excluded as these would not be per-
formed by an assistant practitioner. The examinations were ran-
domly mixed and the mammographers’ identifiers on the films
obscured. The oblique views were assessed by an experienced
radiographer (DS) using a simple satisfactory/unsatisfactory
scoring system for each of nine variables.
The images produced by the assistant practitioner were slightly
less likely to be symmetrical, but otherwise there was no signifi-
cant difference in the quality of the images produced by the
assistant practitioner compared with those produced by the
radiographers. The findings confirm that assistant practitioners
can make a valuable contribution to the Breast Screening Pro-
gramme.
49 Great, I’ve been let off the hook (the impact of advanced practice within the breast screening
department)
C Lewis and MG Wallis
Warwickshire, Solihull & Coventry Breast Screening Unit, Coventry & Warwickshire Hospital, Coventry, UK
The role of advanced practitioner enables the radiologist to
work more efficiently. Wire localisations are essential proce-
dures but by using a radiographer who has been trained to
undertake them, this leaves the radiologist time to film read
without interruption most mornings.
As the advanced practitioner can perform stereocores, the
assessment and symptomatic clinics are able to run more effi-
ciently. The outcome is to minimise stress, streamline the
service and promote a patient-focused quality service (i.e.
shorter waiting times for results, minimise repeat attendance).
Audit of these procedures for radiologists and radiographers
indicate that the results are very similar.
A radiologist commented, “It’s great, I’ve been let off the hook!
Peace to read most mornings.”
50 Technical recalls and technical repeats: evaluating the effect of the Occupational Standards/Skill
Mix project
ME Wheaton and V Gilks
Warwickshire, Solihull & Coventry Breast Screening Unit, Coventry & Warwickshire Hospital, Coventry, UK
As a pilot site for the Occupational Standards/Skill Mix project,
it was agreed at the outset that one of the evaluation criteria
would be the effect the project had on our technical recall and
technical repeat rate. In particular, concern has been raised
that trained assistant practitioners may have a higher technical
recall/repeat rate than trained radiographers.
Technical recall and repeat data are routinely collected and
documented by all mammographers working within our service
and stored on the National Breast Screening Computer
System (NBSS). These data are analysed monthly for technical
recall rate, technical repeat rate and overall rate, including indi-
vidual mammographers’ rates, using a co-writer report from
NBSS.
We are currently performing a detailed evaluation of these
rates for the 3-month period following the completion of the
project, specifically comparing the technical recall/repeat rates
of the two newly trained assistant practitioners with two newly
trained radiographers, to see if the concern is justified.Available online http://breast-cancer-research.com/supplements/4/S1
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51 National Vocational Qualifications (NVQs): a learning experience
V Gilks and J Ng
Warwickshire, Solihull & Coventry Breast Screening Unit, Coventry & Warwickshire Hospital, Coventry, UK
As a pilot site for the Occupational Standards/Skill Mix project
in breast screening, the Warwickshire, Solihull and Coventry
Breast Screening Service appointed two trainee assistant prac-
titioners. Besides their practical mammography training, it was
decided they should follow the National Vocational Qualification
(NVQ) award course ‘Diagnostic and Therapeutic Support in
Care’ level 3. This type of learning was new to us and probably
new to most breast screening and X-ray departments.
We present a short explanation of the NVQ system, together
with a description of benefits to others who may be contem-
plating following in our footsteps.
52 Extending the screening programme: how we did it and lived to tell the tale!
V Gilks and ME Wheaton
Warwickshire, Solihull & Coventry Breast Screening Unit, Coventry & Warwickshire Hospital, Coventry, UK
As a pilot site for the Occupational Standards/Skill Mix project,
by Christmas 2000 we had become aware that this also meant
that we were expected to extend the screening programme up to
the age of 70 and introduce two views on all women, before the
end of March 2002. This poster takes a light-hearted pictorial
view of our journey from then to 4 February 2002 and beyond.
53 Assistant practitioners: a success story
R Lander and S Milton
Breast Screening Unit, The Jarvis Breast Screening Training and Diagnostic Centre, Guildford, UK
The objective of this poster is to show how assistant practi-
tioners fit into a busy breast-screening department. Four
support workers were employed from August 2001, all
having care related backgrounds. It was unclear at the outset
exactly what their duties would be and to whom they would
be responsible on a day-to-day basis. The girls were all
placed on a National Vocational Qualification (NVQ) course
level 3 in Diagnostic and Therapeutic Support on an acceler-
ated basis to complete in 9 months instead of 12, and four
radiographers are currently undertaking NVQ Assessors
awards in order to support them. The first 3 months were dif-
ficult for both staff and trainees, and they were employed
according to the department’s needs. One girl ultimately
made the decision that the job wasn’t for her. The girls
started mammography training in January 2002, each one
working one-to-one with a trainer for 2 weeks initially and
with regular reviews, and all are producing good quality
mammograms. They also undertake nursing, processing and
office duties where possible. Our three remaining girls have
been renamed assistant practitioners after the Occupational
Standards were set and are a great asset to our department
in all the areas they work in.
54 Complications of breast core biopsy
A O’Connor, EJ Wylie and LJ Nuttall
Breast Assessment Centre, Royal Perth Hospital, Perth, Australia
A pictorial review of some of the complications of breast core
biopsy is presented. Core biopsy of the breast is a commonly
performed procedure that plays a vital role in the investigation
of suspected breast cancer. Serious complications related to
it are rare. The commonest problem is bleeding, which is
usually easy to control at the time of the procedure. Arterial
bleeding usually leads to the procedure being abandoned and
repeated later. Applying pressure normally brings arterial
bleeding under control within 15 min. Lesser degrees of
haematoma can result in the lesion being obscured, which
prevents a representative biopsy being obtained. In these
cases repeat biopsy after an interval of 2 weeks allows the
haematoma to resolve.
Rarer complications of core biopsy include infection and
abscess formation, pneumothorax, milk fistula formation, cos-
metic deformity and seeding of tumour along the biopsy track.
Complete removal of a mammographic abnormality such as
microcalcifications can result in difficulty if localisation for exci-
sion is required.Breast Cancer Research    Vol 4 Suppl 1 Symposium Mammographicum 2002
S18
55 Pre-operative fine-needle aspiration cytology (FNAC) and core biopsy (CB) of radial scars (RS)
and complex sclerosing lesions (CSL)
DC Windmill, RM Watkins, C Holgate, JR Steel and PA Jones
Primrose Breast Care Centre, Derriford Hospital, Plymouth, UK
Many screen-detected radial scars (RS) and complex scleros-
ing lesions (CSL) are associated with malignant disease, and
the role of fine-needle aspiration cytology (FNAC) and core
biopsy (CB) in pre-operative evaluation remains uncertain. Our
aim was to determine the diagnostic accuracy of FNAC and
CB in the management of these lesions. The results of FNAC
and CB in 54 women (age range 36–72 years) with a definitive
diagnosis of RS or CSL at excision biopsy between January
1997 and January 2002 were reviewed. FNAC in 37 patients
was inadequate in 15 (41%). Sixteen patients were classified
as C2 (43%), three as C3 (8%), one as C4 (3%) and two as
C5 (5%). CB in 37 patients was graded as B1 in four patients
(11%), B2 in 27 (73%), B3 in four (11%) and B4 in two (5%).
Four cases of ductal carcinoma in situ and three of invasive
carcinoma were identified following excision biopsy. None was
diagnosed pre-operatively by CB. One invasive carcinoma was
diagnosed on FNAC. One patient was classified as B4 on CB.
Another patient had a false positive result on FNAC. Only 11
out of 37 women (30%) had a positive diagnosis of RS or CSL
on pre-operative CB. A further seven women (19%) had CB
results suggestive of RS or CSL.
Pre-operative FNAC and CB are insufficient to accurately diag-
nose significant pathology associated with RS or CSL. Excision
biopsy remains essential.
56 Decubitus position for horizontal approach mammotome: is it possible?
E Lightfoot1, A Pavis1, A Murphy1 and J Berry-Smith2
1North Yorkshire Breast Screening Service, York District Hospital, York, UK and 2GE Medical Systems
The objective of this poster is to assess the feasibility of using
the decubitus position for horizontal arm mammotome biopsy
on upright stereotactic equipment. Illustrated examples of the
preferred approach for lesions in each of the four quadrants of
the breast shall be included.
57 Evaluation of the need for magnification views in the assessment of calcification in
computerised mammography
G Wivell, R Hiscock, M Trotter, M Shaw, J Pilling and ERE Denton
Breast Imaging Department, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
Magnification views are routinely used for the assessment of
breast calcification. Computerised radiography may eliminate
the need for magnification views as such images can be magni-
fied on the computer console. This study evaluates the addi-
tional information gained from computerised magnification
views in the mammographic workup of 100 women presenting
with calcification on screening or follow-up mammography. The
ability of our Fuji computerised radiography with General Elec-
tric’s PACS equipment to display standard mammographic test
tools (TORMAS and TORMAM) is also evaluated.
58 Welcome to North Wales breast screening
W Thomas
North Wales Breast Screening Centre, Llandudno, UK
The content of this poster initially depicts the working prac-
tice and location of our department. As this is the first poster
from Breast Test Wales, we felt it was important to include
some of our background history. The second part of the
poster presents the results of recent surveys undertaken at
Breast Test Wales. The first survey shows the effect of
increasing the kV to 34 to perform magnification views in
mammography. The second survey concerns the T/R rate
during assessment clinics, with some additional information
on the general T/R rate.
59 To mag or not mag: that was the question?
S Laybourne, J Austin, G Brown and J MacDonald
Department of Radiology, The Royal Marsden NHS Trust, Sutton, UK
Aims: (1) To compare digital magnification views with zoomed
images on the Senographe 2000D workstation. (2) To
compare the number of digital magnification views to analogue
magnification over a period of 1 year.
Method: Over a 1-year period an assessment was made as to
whether a radiologist could determine a difference between
zoomed images and magnified digital images. In addition, a com-
parison was made with the number of requests for magnificationAvailable online http://breast-cancer-research.com/supplements/4/S1
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views in the first year of full field digital mammography (FFDM)
compared with the same period prior to installation of FFDM.
Results: Radiologists could not see a difference when compar-
ing zoomed or magnified images. It was noted that in the 1-year
period following FFDM installation requests for magnification
views had fallen by 80%.
Conclusion: We conclude that the introduction of digital mam-
mography has reduced patient dose, where additional magni-
fied views would have been required. We believe this has
benefited the service by reducing patient anxiety and waiting
list through reduced mammographic recalls for additional
views.
60 An evaluation of the current role of radiographer film readers in breast screening
B Williams and PN Brown
Breast Screening Centre, Breast Test Wales, Swansea, UK
Literature suggests that both the government and professional
bodies are supportive of role development and changing of
professional boundaries, but is this representative of current
clinical practice?
All 97 mainland UK National Health Service Breast Screening
Programme (NHSBSP) centres were surveyed. Postal ques-
tionnaires were sent to both radiographer film readers and
departmental superintendent radiographers centring on practi-
cal, clinical and managerial issues concerning the current prac-
tice and implementation of extended roles. An overall response
rate of 79% was achieved. Of radiographers working in breast
screening, 10% are trained in image interpretation and report-
ing in mammography. Only 43% of these read annually a
minimum of 5,000 mammograms – the quality guidelines for
radiologists. Many barriers inhibiting the utilisation of radiogra-
pher film readers were identified:
1. Resource constraints, both human and financial
2. Time constraints
3. Quality assurance issues
4. National structure.
This study demonstrated under-utilisation of radiographer film
readers in the UK NHSBSP, raising the issue of ‘Is training
radiographers to film read an efficient and effective use of
scarce health care resources?’
Further research into this contentious issue is necessary to fully
evaluate and ensure effective use of clinical skills; better
service to the patient; and efficient use of health care
resources is undertaken.
61 Changes in reporting practices with time when radiographers and radiologists double read
screening mammograms
CB Eve, ERE Denton and M Ballantyne
Breast Imaging Department, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
We have previously presented our experience of double
reading screening mammograms by radiologists and trained
radiographers. Our initial data showed that radiographers more
readily detect calcification and smaller cancers compared to
radiologists, who more readily detected larger cancers and
higher grade tumours. To evaluate whether these differences
have persisted with time, we have reviewed the last 4 years’
data and compared the first 30,000 screening mammograms
double read by radiographer and radiologist to the subsequent
30,000. The radiographers persistently detect malignant calcifi-
cation more successfully than the radiologists. Differences in all
other parameters have reduced. The group of film readers in
our unit have not gravitated to a common mid point with time
but have changed with time and reduced the differences in
detection of all radiographic abnormalities except for calcifica-
tion. We will present these data in detail and discuss possible
reasons for persistent differences between the two groups of
readers in detection of malignant calcification.
62 Are there demographic differences in film reading skill?
AG Gale, HC Cowley, SM Bateman and DS Wooding
Institute of Behavioural Sciences, University of Derby, Derby, UK
Since 1991, the majority of UK breast screening radiologists
have annually taken part in the Personal Performance in Mam-
mographic Screening (PERFORMS) self-assessment scheme.
In addition to reporting a set of difficult mammographic cases,
they have also completed a questionnaire where they indicated
their normal screening practices (e.g. number of cases read
per week, mammographic views used and the time of day they
usually read screening cases) and demographic details (e.g.
age, gender and experience).
The purpose of this study was to determine whether there were
any correlations between these questionnaire data and the
various performance measures provided by the self-assess-
ment film sets. Additionally, any change in response to theBreast Cancer Research    Vol 4 Suppl 1 Symposium Mammographicum 2002
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questionnaire over time was examined. All data presented are
anonymous. There were no significant differences for gender,
but significant correlations were found for some of the ques-
tionnaire responses and performance. For example, experience
and the number of cases read per week were positively corre-
lated with some performance measures.
In conclusion, different screening practices and some demo-
graphic differences can have an effect on an individual’s perfor-
mance in interpreting a self-assessment film set. This finding
may also be applicable to actual breast screening performance.
63 The establishment of an assessment method for radiographers to undertake mammographic
image interpretation and reporting
J Horrocks
Department of Imaging Sciences, School of Healthcare Studies, The University of Leeds, Leeds, UK
The radiographic report is a communication channel for the
reporter to the referring clinician. It is sometimes crucial in
major decisions and may have legal significance [1]. The
problem for the educationalist when assessing radiographers
to undertake mammographic image reporting is that there is no
performance standard [2]. This research was undertaken to
establish an assessment method for mammographic image
interpretation and reporting that was valid, reliable and fair [3].
Objectives: To develop an assessment form for mammo-
graphic reading/reporting. To determine the number of cases
for reporting in the allocated assessment time. To propose the
mark weighting for each section of the assessment form. To
establish a pass mark.
Results: The agreed format for the assessment form was as
follows: four sections headed clinical details, radiological
observations, appropriate response and conclusion (including
recommendations if appropriate). Ten cases were to be under-
taken per hourly assessment. Twenty marks were allocated to
each case, the observation section holding the greatest weight-
ing. The pass mark required 100 marks from the available 200
– a fail for four cases being misinterpreted.
Modification following re-evaluation after implementation:
The assessment time was increased. One hundred marks plus
70% agreement in appropriate response section was required
for a pass.
References
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64 Assessing performance of screen readers in the National Health Service Breast Screening
Programme (NHSBSP)
JC Liston
Leeds/Wakefield Breast Screening Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Rapid expansion of the National Health Service Breast
Screening Programme (NHSBSP) will result in many new
readers undertaking the task of screen reading. A timely
method for assessing performance (sensitivity and specificity),
and preferably one that facilitates a steep learning curve, will
be required. Since 1995, 90% of films have been double read
at this unit. A manual record is kept of cancers detected
through double reading and subsequent 3rd reader arbitration.
The number of cases read and individuals’ recall rates, when
acting as the 1st reader, were obtained by running an annual
co-writer report. A total of 150,344 women were screened
between April 1995 and March 2001, resulting in the detec-
tion of 880 cancers. Sixty-six (7.5%) were detected following
arbitration. There was variation both in recall to assessment
rates and in the number of cases incorrectly returned to
routine recall between readers. Prompt feedback of ‘missed’
cases allowed readers to modify their recall thresholds for par-
ticular mammographic abnormalities. If the cases had been
single read the reader would have remained unaware of the
‘miss’ until the woman presented symptomatically with an
interval cancer or the cancer was detected at the next screen-
ing round. It is recommended that the National Screening
Committee review the policy of single versus double reading in
the NHSBSP.
65 Analysis of results of the X-ray mammography in diagnostics on breast cancer
E Vetukh and T Davidovich
Department of Radiodiagnosis, Regional Clinical Oncological Centre, Gomel, Belarus
We examined 2,134 women; breast cancer was detected in
216. One hundred and forty cases were subjected to an in-
depth analysis: stage I was detected in 25 patients, stage II in
60, stage III in 46 and stage IV in 9. In 5% of the cases,
tumours were inpalpable and could be detected by X-ray only.
In 8.7 of the cases, the multicentric nature of tumour growth
was established. In 62% tumours were of mixed histological
structure. Breast cancer recognition provided accurate diagno-Available online http://breast-cancer-research.com/supplements/4/S1
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sis in 98%. Good diagnostic results are possible under special
conditions in a mammology unit where a röntgenologist works
in close contact with surgeons and morphologists. We perform
all stages of diagnosis beginning with the clinical examination
proceeding to special methods requiring X-ray control (para-
centesis, ductography, pneumocystography, pre-operative
marking of the breast and marking of the remote sectors of the
breast).
66 Is it safe to allow general practitioners open access to breast imaging?
GR Clough, A Hill and JC Liston
Breast Care Unit, St James’s University Hospital, Leeds, UK
Many departments in the UK do not allow general practitioners
open access for breast imaging. Royal College of Radiologists
guidelines [1] published in 1999 recommend that direct refer-
ral of women by general practitioners for breast imaging should
be controlled so that women with conditions requiring referral
to a breast surgeon [2] are not inappropriately managed. To
avoid overwhelming the already busy symptomatic breast
clinics in Leeds, it was decided that direct access for breast
imaging should continue but be audited.
Between May 2000 and April 2001, 491 patients were
referred with a variety of symptoms, including 173 women with
mastalgia and 130 women with a palpable lump. If imaging was
normal, then the report advised referral to the breast clinic if the
palpable abnormality persisted. Women with a mammographic
or ultrasound abnormality requiring biopsy were recalled by the
imaging department and 22 women underwent needle biopsy.
All attended the next breast clinic for clinical examination and
discussion of their results. Three cancers were diagnosed but
none presented with a palpable lump. Open access for breast
imaging is safe if controlled.
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67 A 10-year review of lymphoma detected by breast screening
A O’Connor and EJ Wylie
Breast Assessment Centre, Royal Perth Hospital, Perth, Australia
Breast cancer and non-Hodgkin’s lymphoma are the commonest
and 7th commonest malignancies in Australian women, with life-
time incidences of 1 in 11 and 1 in 98. Lymphoma of the breast
accounts for 0.5% of all lymphomas. BreastScreen WA records
from 1990 to 2000 were searched for lymphoma. During this
time, 450,421 women were screened and 2,314 cases of malig-
nancy detected. Eight cases were detected. Patients’ ages
ranged from 52 to 84. Two were symptomatic, with tiredness
and inguinal lymphadenopathy respectively. The abnormality was
axillary lymphadenopathy in four cases, intramammary masses in
three patients, and both in one case. Intramammary masses were
investigated as for any indeterminate lesion. Nodes exceeding 2
cm without a fatty centre were seen in three cases. In the other
two cases they were less than 2 cm long but had enlarged. The
possibility of lymphoma was considered before biopsy in three
cases, all axillary lymphadenopathy. Diagnosis was confirmed by
open biopsy in seven cases. There were seven cases of low
grade non-Hodgkin’s lymphoma, and one case of intermediate
grade. Lymphoma can be detected on screening mammograms
as an intramammary mass or as axillary lymphadenopathy.
68 An audit of benign biopsies performed in patients assessed by the Leeds/Wakefield Breast
Screening Unit
PJ Carder1 and JC Liston2
1Pathology Department, St James’s University Hospital, and 2Leeds/Wakefield Breast Screening Service, Seacroft Hospital, Leeds, UK
This audit was performed in order to clarify any relationship
between an increase in benign biopsies and use of the B3 core
biopsy category. Women who had been screened between 1
April 1999 and 31 March 2000 by Leeds/Wakefield Breast
Screening Service and who had undergone a surgical biopsy
for a lesion subsequently proving benign were identified and all
pre-operative investigations reviewed. Thirty-six women had
undergone a surgical excision biopsy for a benign lesion and 22
of these (61%) had had a B3 biopsy categorisation. Twelve of
these reflected a pathological suggestion of radial scar but
there were 10 others and a wide variety of lesions were repre-
sented. Two papillary lesions, two fibro-epithelial lesions, two
difficult intraductal epithelial proliferations and two biopsies con-
taining pools of stromal mucin were found, as was one case of
atypical lobular hyperplasia and one unusual vascular lesion.
We suggest there may be a relationship between the histologi-
cal uncertainty, which may arise as a consequence of the limited
sampling of core biopsy and a rise in the number of benign
biopsies performed. It is possible that newer vacuum assisted
techniques such as the mammotome may prove helpful in avoid-
ing the need for open biopsy in some of these patients.69 Diagnosis of dermal calcification
D McBurnie on behalf of North Yorkshire Breast Screening Unit
North Yorkshire Breast Screening Service, York District Hospital, York, UK
This presentation will illustrate how the combination of estab-
lished mammographic techniques and the alternative use of a
biopsy attachment helped us to develop a technique that
allows differential radiological diagnosis between dermal calci-
fication and other calcification within breast tissue.
The accurate radiological diagnosis of dermal calcification has
many advantages: the possible prevention of unnecessary
biopsy procedures; results can be given on the first visit; reduc-
tion of patient time in department; and reduction of patient
anxiety induced by both biopsy and the wait for results.
Dermal calcifications typically have lucent centres and maintain
their positional relationships regardless of radiographic view (the
tattoo sign). It is the maintenance of these positional relation-
ships that enables a possible diagnosis of dermal calcification.
Confirmation of this diagnosis can be made using the Siemens
Mammomat 3000 and biopsy attachment with shadow cross. It
is possible to accurately locate and subsequently skin mark the
calcification. Tangential views are taken following the skin
marking. If the calcifications are found to be within 3 mm of the
skin marker the diagnosis of dermal calcifications can be made.
70 Phylloides tumours: review of 42 cases
S Chandrasekharan, FA Macneill, SK Marsh, P Sauven and R Whitney
Colchester and Chelmsford Breast Unit, Essex County Hospital, Colchester, UK
Aim: This is a review of 42 cases of phylloides tumours seen in
the two breast units over a 5-year period (1996–2001). The
importance of triple assessment and particularly correlation
between radiology and cytology is shown.
Methods and results: All patients with confirmed histology
report of phylloides tumours were included in the study. The
age range of patients was 23–76. One patient had bilateral
phylloides tumour. Twenty-four patients had an R3 score and
36 patients had a U3 score. Thirty-seven patients had C3
score. Nineteen patients had core biopsy, which confirmed
phylloides tumour. Four patients had B1 core and 14 patients
preferred excision to core biopsy. Thirty-six patients had benign
phylloides tumour and six patients had malignant phylloides.
Discussion: Clinically, most of the benign phylloides were
diagnosed as fibro-adenomas. However, as can be seen in the
data above, many phylloides tumours do have a slightly atypical
appearance either on radiology or cytology, or both. The multi-
disciplinary team reviewed all these patients before a decision
for surgery was made and all histology was reviewed.
Conclusion: Triple assessment and multidisciplinary team
approach is essential for all atypical radiology or cytology scores.
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2 Hormone replacement therapy (HRT): indications and side-effects
MI Whitehead
Menopause Clinic, King’s College Hospital, London, UK
Hormone replacement therapy (HRT) has been prescribed to
relieve typical oestrogen deficiency symptoms, conserve post-
menopausal bone and thereby reduce the risk of osteoporotic
fracture, and also to reduce the risk of certain arterial diseases
such as ischaemic heart disease (IHD).
Numerous placebo-controlled studies have confirmed that
oestrogens reduce the frequency and severity of flushes and
sweats, and also improve vaginal dryness. Although not consis-
tent, some data report an improvement in psychological symp-
toms such as poor memory and concentration. At appropriate
daily dose, oestrogens reduce postmenopausal bone loss in
both spine and hip; data on fracture efficacy from controlled
studies at both of these sites are lacking, but observational
data report reductions in fracture risk.
The effects of HRT in women with risk factors for IHD are con-
troversial, with some studies reporting benefits but others not.
The majority of the observational data in apparently fit and
healthy younger women report an approximate 50% reduction
in IHD with use of HRT.
The major long-term concern of use of HRT is risk of breast
cancer. There is an approximate threefold excess risk of venous
thrombosis with all forms of therapy and an approximate 60%
excess risk of gallstones with oral therapy. Other side effects
tend to be short-lived and include breast tenderness (due to
the oestrogen) and a PMT-like complex (due to the progesto-
gen). Numerous studies report no significant effect on weight,
systolic or diastolic blood pressure.